Physical Activity, Exercise Capacity and Sedentary Behavior in People with Alpha-1 Antitrypsin Deficiency: A Scoping Review

References

• Miravitlles M, Dirksen A, Ferrarotti I, et al. European Respiratory Society statement: diagnosis and treatment of pulmonary disease in α 1 -antitrypsin deficiency. Eur Respir J. 2017;50(5):1700610. doi:10.1183/13993003.00610-2017
   PubMed Web of Science ®Google Scholar
• Franciosi AN, Hobbs BD, McElvaney OJ, et al. Clarifying the risk of lung disease in SZ alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med. 2020;202(1):73–82. doi:10.1164/rccm.202002-0262OC
   PubMed Web of Science ®Google Scholar
• McElvaney NG, Stoller JK, Buist AS, et al.; Group1 taDRS. Baseline characteristics of enrollees in the national heart, lung and blood InstituteRegistry of a-,-antitrypsin deficiency*. Chest. 1997;11:395–403.
   Google Scholar
• Janoff A, White R, Carp H, Harel S, Dearing R, Lee D. Lung injury induced by leukocytic proteases. Am J Pathol. 1979;97(1):111–136.
   PubMed Web of Science ®Google Scholar
• Lomas DA, Li-Evans D, Finch JT, Carrell RW. The mechanism of Z α1-antitrypsin accumulation in the liver. Nature. 1992;357(6379):605–607. doi:10.1038/357605a0
   PubMed Web of Science ®Google Scholar
• Sveger T. Liver disease in alpha 1-antitrypsin deficiency detected by screening of 200,000 infants. N Engl J Med. 1976;294(24):1316–1321. doi:10.1056/NEJM197606102942404
   PubMed Web of Science ®Google Scholar
• Franciosi AN, Carroll TP, McElvaney NG. Pitfalls and caveats in α1-antitrypsin deficiency testing: a guide for clinicians. Lancet Respir Med. 2019;7(12):1059–1067. doi:10.1016/S2213-2600(19)30141-9
   PubMed Web of Science ®Google Scholar
• Caspersen CJ, PowelL KE, Christenson GM. Physical activity, exercise and physical fitness: definitions and distinctions for health-related research. Public Helath Rep. 1985;100(2):154.
   Web of Science ®Google Scholar
• uk-chief-medical-officers-physical-activity-guidelines; 2019. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/832868/uk-chief-medical-officers-physical-activity-guidelines.pdf. Accessed February 2, 2023.
   Google Scholar
• Bull FC, Al-Ansari SS, Biddle S, et al. World Health Organization 2020 guidelines on physical activity and sedentary behaviour. Br J Sports Med. 2020;54(24):1451–1462. doi:10.1136/bjsports-2020-102955
   PubMed Web of Science ®Google Scholar
• Marley J, Tully MA, Porter-Armstrong A, et al. The effectiveness of interventions aimed at increasing physical activity in adults with persistent musculoskeletal pain: a systematic review and meta-analysis. BMC Musculoskelet Disord. 2017;18(1):482. doi:10.1186/s12891-017-1836-2
   PubMedGoogle Scholar
• Bolton CE, Bevan-Smith EF, Blakey JD, et al. British Thoracic Society guideline on pulmonary rehabilitation in adults: accredited by NICE. Thorax. 2013;68:ii1–ii30. doi:10.1136/thoraxjnl-2013-203808
   PubMed Web of Science ®Google Scholar
• Pitta F, Troosters T, Spruit MA, Probst VS, Decramer M, Gosselink R. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;171(9):972–977. doi:10.1164/rccm.200407-855OC
   PubMed Web of Science ®Google Scholar
• Jose A, Ramos TM, de Castro RAS, et al. Reduced physical activity with bronchiectasis. Respir Care. 2018;63(12):1498–1505. doi:10.4187/respcare.05771
   PubMed Web of Science ®Google Scholar
• Nishiyama O, Yamazaki R, Sano H, et al. Physical activity in daily life in patients with idiopathic pulmonary fibrosis. Respir Investig. 2018;56(1):57–63. doi:10.1016/j.resinv.2017.09.004
   PubMed Web of Science ®Google Scholar
• Choate R, Mannino DM, Holm KE, Beiko T, Boyd B, Sandhaus RA. Home-based multicomponent intervention increases exercise activity and improves body mass index: results of a 5-year randomized trial among individuals with alpha-1 antitrypsin deficiency-associated lung disease. Chronic Obstr Pulm Dis. 2021;8(1):25.
   Web of Science ®Google Scholar
• Tremblay MS, Aubert S, Barnes JD, et al. Sedentary Behavior Research Network (SBRN) - terminology consensus project process and outcome. Int J Behav Nutr Phys Act. 2017;14(1):75. doi:10.1186/s12966-017-0525-8
   PubMed Web of Science ®Google Scholar
• Green CE, Vayalapra S, Hampson JA, Mukherjee D, Stockley RA, Turner AM. PiSZ alpha-1 antitrypsin deficiency (AATD): pulmonary phenotype and prognosis relative to PiZZ AATD and PiMM COPD. Thorax. 2015;70(10):939–945. doi:10.1136/thoraxjnl-2015-206906
   PubMed Web of Science ®Google Scholar
• Chapman KR, Chorostowska-Wynimko J, Koczulla AR, Ferrarotti I, McElvaney NG. Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications. Int J Chron Obstruct Pulmon Dis. 2018;13:419–432. doi:10.2147/COPD.S149429
   PubMed Web of Science ®Google Scholar
• Carone M, Pennisi A, D’Amato M, et al. Physical functioning in patients with chronic obstructive pulmonary disease treated with tiotropium/olodaterol respimat in routine clinical practice in Italy. Pulmon Ther. 2020;6(2):261–274. doi:10.1007/s41030-020-00122-9
   PubMedGoogle Scholar
• Wewers MD, Casolaro MA, Sellers SE, et al. Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema. N Engl J Med. 1987;316(17):1055–1062. doi:10.1056/NEJM198704233161704
   PubMed Web of Science ®Google Scholar
• Moy ML, Danilack VA, Weston NA, Garshick E. Daily step counts in a US cohort with COPD. Respir Med. 2012;106(7):962–969. doi:10.1016/j.rmed.2012.03.016
   PubMed Web of Science ®Google Scholar
• Tricco AC, Lillie E, Zarin W, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467–473. doi:10.7326/M18-0850
   PubMed Web of Science ®Google Scholar
• Wencker M, Konietzko N. Blood gases at rest and during exercise in patients with alpha 1-Pi deficiency. Respir Med. 2000;94(12):1177–1183. doi:10.1053/rmed.2000.0947
   PubMed Web of Science ®Google Scholar
• Perkins JT, Choate R, Mannino DM, Browning SR, Sandhaus RA. Benefits among patients with alpha-1 antitrypsin deficiency enrolled in a disease management and prevention program. Chronic Obstr Pulm Dis. 2016;4(1):56–64. doi:10.15326/jcopdf.4.1.2016.0161
   PubMedGoogle Scholar
• Olfert IM, Malek MH, Eagan TML, Wagner H, Wagner PD. Inflammatory cytokine response to exercise in alpha-1-antitrypsin deficient COPD patients ‘on’ or ‘off’ augmentation therapy. BMC Pulm Med. 2014;14(1):106. doi:10.1186/1471-2466-14-106
   PubMedGoogle Scholar
• Kohnlein T, Janciauskiene S, Welte T. Diagnostic delay and clinical modifiers in alpha-1 antitrypsin deficiency. Ther Adv Respir Dis. 2010;4(5):279–287. doi:10.1177/1753465810376407
   PubMedGoogle Scholar
• Holm KE, Mannino DM, Choate R, Sandhaus RA. Genotype is associated with smoking and other key health behaviors among individuals with alpha-1 antitrypsin deficiency-associated lung disease. Respir Med. 2018;143:48–55. doi:10.1016/j.rmed.2018.08.016
   PubMed Web of Science ®Google Scholar
• Dowson LJ, Newall C, Guest PJ, Hill SL, Stockley RA. Exercise capacity predicts health status in alpha 1-antitrypsin deficiency. Am J Respir Crit Care Med. 2001;163:936–941.
   PubMed Web of Science ®Google Scholar
• Thabut G, Mornex JF, Pison C, et al. Performance of the BODE index in patients with alpha 1-antitrypsin deficiency-related COPD. Eur Respir J. 2014;44(1):78–86. doi:10.1183/09031936.00168113
   PubMed Web of Science ®Google Scholar
• Jarosch I, Gehlert S, Jacko D, et al. Different training-induced skeletal muscle adaptations in COPD patients with and without alpha-1 antitrypsin deficiency. Respiration. 2016;92(5):339–347. doi:10.1159/000449509
   PubMed Web of Science ®Google Scholar
• Cassina PC, Teschler H, Konietzko N, Theegarten D, Stamatis G. Two-year results after lung volume reduction surgery in alpha 1-antitrypsin deficiency versus smoker’s emphysema. Eur Respir J. 1998;12(5):1028–1032. doi:10.1183/09031936.98.12051028
   PubMed Web of Science ®Google Scholar
• Tutic M, Bloch KE, Lardinois D, Brack T, Russi EW, Weder W. Long-term results after lung volume reduction surgery in patients with alpha 1-antitrypsin deficiency. J Thorac Cardiovasc Surg. 2004;128(3):408–413. doi:10.1016/j.jtcvs.2004.03.040
   PubMed Web of Science ®Google Scholar
• Tanash HA, Riise GC, Hansson L, Nilsson PM, Piitulainen E. Survival benefit of lung transplantation in individuals with severe alpha 1-anti-trypsin deficiency (PiZZ) and emphysema. J Heart Lung Transplant. 2011;30(12):1342–1347. doi:10.1016/j.healun.2011.07.003
   PubMed Web of Science ®Google Scholar
• Dauriat G, Mal H, Jebrak G, et al. Functional results of unilateral lung volume reduction surgery in alpha1-antitrypsin deficient patients (1). Int J COPD. 2006;1:201–207.
   Google Scholar
• Tanash HA, Riise GC, Ekstrom MP, Hansson L, Piitulainen E. Survival benefit of lung transplantation for chronic obstructive pulmonary disease in Sweden. Ann Thorac Surg. 2014;98(6):1930–1935. doi:10.1016/j.athoracsur.2014.07.030
   PubMed Web of Science ®Google Scholar
• Jarosch I, Hitzl W, Koczulla AR, et al. Comparison of exercise training responses in COPD patients with and without Alpha-1 antitrypsin deficiency. Respir Med. 2017;130:98–101. doi:10.1016/j.rmed.2017.07.009
   PubMed Web of Science ®Google Scholar
• Kenn K, Gloeckl R, Soennichsen A, et al. Predictors of success for pulmonary rehabilitation in patients awaiting lung transplantation. Transplantation. 2015;99(5):1072–1077. doi:10.1097/TP.0000000000000472
   PubMed Web of Science ®Google Scholar
• Stoller JK, Gildea TR, Ries AL, Meli YM, Karafa MT; National Emphysema Treatment Trial Research Group. Lung volume reduction surgery in patients with emphysema and alpha-1 antitrypsin deficiency. Ann Thorac Surg. 2007;83(1):241–251. doi:10.1016/j.athoracsur.2006.07.080
   PubMed Web of Science ®Google Scholar
• Stoller JK, Aboussouan LS, Kanner RE, et al. Characteristics of alpha-1 antitrypsin-deficient individuals in the long-term oxygen treatment trial and comparison with other subjects with chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2015;12(12):1796–1804. doi:10.1513/AnnalsATS.201506-389OC
   PubMed Web of Science ®Google Scholar
• Campos MA, Alazemi S, Zhang G, Wanner A, Sandhaus RA. Effects of a disease management program in individuals with alpha-1 antitrypsin deficiency. COPD. 2009;6(1):31–40. doi:10.1080/15412550802607410
   PubMedGoogle Scholar
• Heinzelmann I, Gehlert S, Welte T, Bloch W, Janciauskiene S, Kenn K. Differences in training response between patients with alpha-1 antitrypsin deficiency and COPD patients. Eur Respir J. 2015;46(59):161.
   Google Scholar
• Czech National Alpha-1 Antitrypsin Registry. Chlumsky (Praha 4, Czech Republic), K. Kusalova (Brno, Czech Republic). 2022:2440.
   Google Scholar
• Balbi B, Vitacca M, Piero C, et al. Pulmonary rehabilitation (PR) in patients with COPD due to alpha-1 antitrypsin deficiency (AATD)- 15 years experience at the Mauge. European Respiratory Society Annual Congress; 2013.
   Google Scholar
• Delage A, Hogarth DK, Zgoda M, Reed M. Endobronchial valve treatment in patients with severe emphysema due to alpha-1 antitrypsin deficiency. Intervent Pulmonol. 2019;2019:1544.
   Google Scholar
• Choate R, Holm K, Sandhaus RA. Increase in exercise activities in alpha-1 antitrypsin deficient patients- results of a randomized trial (1). Am J Respir Crit Care Med. 2017;2017:654.
   Google Scholar
• Tseng S, Vick L, Sue R, Alalawi R. Exercise ventilation perfusion scan with single photon emission Ct to assess target lobe for endobronchial valve placement. Chest. 2019;156(4):A28. doi:10.1016/j.chest.2019.08.131
   Web of Science ®Google Scholar
• Menon S, Ahmad M, Khan F, Malik A. Alpha 1 antitrypsin deficiency with normal levels presenting as a diagnostic challenge. Am J Respir Crit Care Med. 2017;24:175.
   Google Scholar
• Murray B, Carroll TP, Fee LT, et al. Examining Diffusing Capacity (DLCO) and functional impairment in a population of ZZ AATD individuals. Ir J Med Sci. 2014;183(Suppl 11):533. doi:10.1007/s11845-013-1044-5
   PubMedGoogle Scholar
• Durkan E, Carroll T, Moyna NM, McElvaney NG. Exercise capacity may be more strongly associated with health status. Am J Respir Crit Care Med. 2019;2019:25.
   Google Scholar
• Heinzelmann GS, Bloch W, Kenn K. Differences in response to pulmonary rehabilitation between COPD patients with and without alpha-1 A. American Thoracic Society International Conference Abstracts; 2015.
   Google Scholar
• Strange C, Senior RM, Sciurba F, et al. Rationale and design of the genomic research in alpha-1 antitrypsin deficiency and sarcoidosis study. alpha-1 protocol. Ann Am Thorac Soc. 2015;12(10):1551–1560. doi:10.1513/AnnalsATS.201503-143OC
   PubMed Web of Science ®Google Scholar
• Greulich T, Altraja A, Barrecheguren M, et al. Protocol for the EARCO registry: a pan-European observational study in patients with α 1 -antitrypsin deficiency. ERJ Open Res. 2020;6(1):00181–2019. doi:10.1183/23120541.00181-2019
   PubMedGoogle Scholar
• Endoscopic lung volume reduction in patients with advanced emphysema due to alpha 1 antitrypsin deficiency. Available from: https://clinicaltrials.gov/ct2/show/NCT01357460. Accessed May 30, 2022.
   Google Scholar
• Evaluate efficacy and safety of “Kamada-AAT for Inhalation” in patients with AATD (InnovAATE). Available from: https://clinicaltrials.gov/ct2/show/NCT04204252. Accessed May 30, 2022.
   Google Scholar
• Effects of different exercise training modalities in alpha-1 antitrypsin deficiency patients. Available from: https://clinicaltrials.gov/ct2/show/NCT03802357. Accessed May 30, 2022.
   Google Scholar
• Zemaira in subjects with emphysema due to alpha 1-proteinase inhibitor deficiency. Available from: https://clinicaltrials.gov/ct2/show/NCT00261833. Accessed May 30, 2022.
   Google Scholar
• Environment effect on six-minute walk test performance (6MWTAATD) Available from: https://clinicaltrials.gov/ct2/show/NCT02502201. Accessed May 30, 2022.
   Google Scholar
• Effects of pulmonary rehabilitation on skeletal muscle in COPD patients. Available from: https://clinicaltrials.gov/ct2/show/NCT02915614. Accessed May 30, 2022.
   Google Scholar
• Lee IM, Shiroma EJ, Lobelo F, et al. Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy. Lancet. 2012;380:219–29. 29. doi:10.1016/S0140-6736(12)61031-9
   PubMed Web of Science ®Google Scholar
• Warburton DER, Bredin SSD. Health benefits of physical activity: a systematic review of current systematic reviews. Curr Opin Cardiol. 2017;32(5):541–556. doi:10.1097/HCO.0000000000000437
   PubMed Web of Science ®Google Scholar
• Waschki B, Kirsten A, Holz O, et al. Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. Chest. 2011;140(2):331–342. doi:10.1378/chest.10-2521
   PubMed Web of Science ®Google Scholar
• Zwerink M, van der Palen J, van der Valk P, Brusse-Keizer M, Effing T. Relationship between daily physical activity and exercise capacity in patients with COPD. Respir Med. 2013;107(2):242–248. doi:10.1016/j.rmed.2012.09.018
   PubMed Web of Science ®Google Scholar
• Spruit MA, Pitta F, McAuley E, ZuWallack RL, Nici L. Pulmonary rehabilitation and physical activity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2015;192(8):924–933. doi:10.1164/rccm.201505-0929CI
   PubMed Web of Science ®Google Scholar
• Hakim A, Moll M, Qiao D, et al. Heterozygosity of the alpha 1-antitrypsin Pi*Z allele and risk of liver disease. Hepatol Commun. 2021;5(8):1348–1361. doi:10.1002/hep4.1718
   PubMed Web of Science ®Google Scholar
• Dunstan DW, Kingwell BA, Larsen R, et al. Breaking up prolonged sitting reduces postprandial glucose and insulin responses. Diabetes Care. 2012;35(5):976–983. doi:10.2337/dc11-1931
   PubMed Web of Science ®Google Scholar
• Dunstan DW, Howard B, Healy GN, Owen N. Too much sitting--a health hazard. Diabetes Res Clin Pract. 2012;97(3):368–376. doi:10.1016/j.diabres.2012.05.020
   PubMed Web of Science ®Google Scholar
• Wu J, Zhang H, Yang L, et al. Sedentary time and the risk of metabolic syndrome: a systematic review and dose-response meta-analysis. Obes Rev. 2022;23(12):e13510. doi:10.1111/obr.13510
   PubMed Web of Science ®Google Scholar
• Negewo NA, Gibson PG, McDonald VM. COPD and its comorbidities: impact, measurement and mechanisms. Respirology. 2015;20(8):1160–1171. doi:10.1111/resp.12642
   PubMed Web of Science ®Google Scholar
• McKeough Z, Cheng SWM, Alison J, Jenkins C, Hamer M, Stamatakis E. Low leisure-based sitting time and being physically active were associated with reduced odds of death and diabetes in people with chronic obstructive pulmonary disease: a cohort study. J Physiother. 2018;64(2):114–120. doi:10.1016/j.jphys.2018.02.007
   PubMed Web of Science ®Google Scholar
• Coll F, Cavalheri V, Gucciardi DF, Wulff S, Hill K. In people with COPD, there is limited evidence that exercise training reduces sedentary time, and behavior change techniques are poorly reported: systematic review and meta-analysis. Phys Ther. 2021;101(7). doi:10.1093/ptj/pzab097
   PubMed Web of Science ®Google Scholar
• Liao SY, Benzo R, Ries AL, Soler X. Physical activity monitoring in patients with chronic obstructive pulmonary disease. Chronic Obstr Pulm Dis. 2014;1(2):155–165. doi:10.15326/jcopdf.1.2.2014.0131
   PubMedGoogle Scholar
• Andersson M, Stridsman C, Ronmark E, Lindberg A, Emtner M. Physical activity and fatigue in chronic obstructive pulmonary disease - a population based study. Respir Med. 2015;109(8):1048–1057. doi:10.1016/j.rmed.2015.05.007
   PubMed Web of Science ®Google Scholar
• Byrom B, Rowe DA. Measuring free-living physical activity in COPD patients: deriving methodology standards for clinical trials through a review of research studies. Contemp Clin Trials. 2016;47:172–184. doi:10.1016/j.cct.2016.01.006
   PubMed Web of Science ®Google Scholar